Fortitude Advisory Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Fortitude Advisory Group's NVS Position: Q2 2022 in Review
Fortitude Advisory Group sold out of Novartis (NVS) in Q2 2022, closing a stake of 1,059 shares — an estimated $93K sold.
Fortitude Advisory Group first reported a position in NVS in Q4 2021 and held it in 2 quarters. The position peaked at $93K in Q1 2022. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.
- Fortitude Advisory Group reported no remaining Novartis position as of Q2 2022 after selling out during the quarter.
- Fortitude Advisory Group sold 1,059 Novartis shares in Q2 2022, an estimated $93K.
- Fortitude Advisory Group first reported a position in Novartis in Q4 2021 and held it in 2 quarters.
- Fortitude Advisory Group's Novartis position peaked at $93K in Q1 2022.
- 1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.
Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.